Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Sep;49(3):532–542.

IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life.

R Melsom, M Harboe, M E Duncan
PMCID: PMC1536716  PMID: 6756719

Abstract

IgA, IgM and IgG anti-M. leprae antibody activity was estimated by solid phase radioimmunoassay in repeated serum samples from cord sera to sera taken 2 years after birth from 29 babies of mothers with lepromatous leprosy (Group 1) and 16 babies of mothers with tuberculoid leprosy and non-leprosy control mothers (Group 2). IgA anti-M. leprae antibody activity could be detected in 30% and IgM anti-M. leprae antibody activity in 50% of cord sera from Group 1, but not in any of the cord sera from Group 2. After birth, there was a significantly higher increase of IgA and IgM anti-M. leprae antibody activity in sera taken 3-6 months after birth from babies of Group 1 compared to Group 2, but the IgA and IgM activity in sera taken after 6 months of age showed the same increase in the two groups. IgG anti-M. leprae antibody activity showed a marked decrease in sera from both Groups 1 and 2 taken 3-6 and 6-9 months after birth compared to the activity in the cord sera. No increase of the IgG activity could be demonstrated even in sera taken 15-24 months after birth in any of the two groups. These findings are discussed in relation to possible transfer of M. leprae bacilli across the placenta, the influence of M. leprae and other mycobacteria exposure on the antibody activity, the poor IgG anti-M. leprae antibody response and subclinical leprosy infection in babies exposed to leprosy below 2 years of age.

Full text

PDF
532

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahams E. W. 'Original mycobacterial sin'. Tubercle. 1970 Sep;51(3):316–321. doi: 10.1016/0041-3879(70)90026-7. [DOI] [PubMed] [Google Scholar]
  2. Beerwerth W., Eysing B., Kessel U. Mykobakterien in Arthropoden verschiedener Biotope. Zentralbl Bakteriol Orig A. 1979 Jun;244(1):50–57. [PubMed] [Google Scholar]
  3. Closs O., Mshana R. N., Harboe M. Antigenic analysis of Mycobacterium leprae. Scand J Immunol. 1979 Mar;9(3):297–302. doi: 10.1111/j.1365-3083.1979.tb02735.x. [DOI] [PubMed] [Google Scholar]
  4. Daniel T. M., Janicki B. W. Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties. Microbiol Rev. 1978 Mar;42(1):84–113. doi: 10.1128/mr.42.1.84-113.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Draper P. Cell walls of Mycobacterium leprae. Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):95–98. [PubMed] [Google Scholar]
  6. Drutz D. J., Chen T. S., Lu W. H. The continuous bacteremia of lepromatous leprosy. N Engl J Med. 1972 Jul 27;287(4):159–164. doi: 10.1056/NEJM197207272870402. [DOI] [PubMed] [Google Scholar]
  7. Duncan M. E., Melsom R., Pearson J. M., Ridley D. S. The association of pregnancy and leprosy. I. New cases, relapse of cured patients and deterioration in patients on treatment during pregnancy and lactation--results of a prospective study of 154 pregnancies in 147 Ethiopian women. Lepr Rev. 1981 Sep;52(3):245–262. doi: 10.5935/0305-7518.19810035. [DOI] [PubMed] [Google Scholar]
  8. Harboe M., Closs O., Bjorvatn B., Kronvall G., Axelsen N. H. Antibody response in rabbits to immunization with Mycobacterium leprae. Infect Immun. 1977 Dec;18(3):792–805. doi: 10.1128/iai.18.3.792-805.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Harboe M., Closs O., Deverill J. Production of monospecific antisera against antigenic componentsof Mycobacterium bovis (BCG). Scand J Immunol. 1976;5(6-7):861–866. doi: 10.1111/j.1365-3083.1976.tb03035.x. [DOI] [PubMed] [Google Scholar]
  10. Harboe M., Fölling I. Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci. Scand J Immunol. 1974;3(4):471–482. doi: 10.1111/j.1365-3083.1974.tb01280.x. [DOI] [PubMed] [Google Scholar]
  11. Harboe M. Radioimmunoassay and other serologic tests and their application in epidemiological work. Lepr Rev. 1981 Dec;52 (Suppl 1):275–288. doi: 10.5935/0305-7518.19810077. [DOI] [PubMed] [Google Scholar]
  12. LARA C. B., NOLASCO J. O. Self-healing, or abortive, and residual forms of childhood leprosy and their probable significance. Int J Lepr. 1956 Jul-Sep;24(3):245–263. [PubMed] [Google Scholar]
  13. March S. C., Parikh I., Cuatrecasas P. A simplified method for cyanogen bromide activation of agarose for affinity chromatography. Anal Biochem. 1974 Jul;60(1):149–152. doi: 10.1016/0003-2697(74)90139-0. [DOI] [PubMed] [Google Scholar]
  14. Melsom R., Duncan M. E., Bjune G. Immunoglobulin concentration in mothers with leprosy and in healthy controls and their babies at the time of birth. Lepr Rev. 1980 Mar;51(1):19–28. doi: 10.5935/0305-7518.19800004. [DOI] [PubMed] [Google Scholar]
  15. Melsom R., Duncan M. E. Demonstration of antibodies against Mycobacterium leprae both in immunoglobulin G and M in sera from pregnant and non-pregnant lepromatous leprosy patients. Lepr Rev. 1980 Jun;51(2):125–135. [PubMed] [Google Scholar]
  16. Melsom R., Duncan M. E., Harboe M., Bjune G. Antibodies against Mycobacterium leprae antigen 7 from birth to 18 months of age: an indicator of intra-uterine infection in leprosy. Clin Exp Immunol. 1980 Oct;42(1):107–113. [PMC free article] [PubMed] [Google Scholar]
  17. Melsom R., Harboe M., Duncan M. E., Bergsvik H. IgA and IgM antibodies against Mycobacterium leprae in cord sera and in patients with leprosy: an indicator of intrauterine infection in leprosy. Scand J Immunol. 1981 Oct;14(4):343–352. doi: 10.1111/j.1365-3083.1981.tb00574.x. [DOI] [PubMed] [Google Scholar]
  18. Melsom R., Harboe M., Myrvang B., Godal T., Belehu A. Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy. Clin Exp Immunol. 1982 Feb;47(2):225–233. [PMC free article] [PubMed] [Google Scholar]
  19. Melsom R., Naafs B., Harboe M., Closs O. Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy. Lepr Rev. 1978 Mar;49(1):17–29. [PubMed] [Google Scholar]
  20. Pabst H. F., Kreth H. W. Ontogeny of the immune response as a basis of childhood disease. J Pediatr. 1980 Oct;97(4):519–534. doi: 10.1016/s0022-3476(80)80003-5. [DOI] [PubMed] [Google Scholar]
  21. Peltola H., Käyhty H., Sivonen A., Mäkelä H. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics. 1977 Nov;60(5):730–737. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES